StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302252% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines Global Full-Time Employees by Year

Global Full-Time Employees (Form 10-K / 10-Q & ESG Report)

QuarterlyAnnual

BeOne Medicines Global Full-Time Employees: 12,000 in FY2025, up 9.1% from a year earlier.

Latest, FY2025
12,000
Period ended Dec 31, 2025
Change on a year earlier
+9.1%
11,000 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-K / 10-Q & BeOne Responsible Business & Sustainability Reports (2019–2025).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGlobal Full-Time Employees (Form 10-K / 10-Q & ESG Report)Year on yearSource
FY2025Dec 31, 202512,000+9.1%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 202411,000+10.0%Form 10-K (filed 2025-02-27) ↗
FY2023Dec 31, 202310,000+11.1%Form 10-K (filed 2024-02-26) ↗
FY2022Dec 31, 20229,000+12.5%Form 10-K (filed 2023-02-27) ↗
FY2021Dec 31, 20218,000+50.9%Form 10-K (filed 2022-02-28) ↗
FY2020Dec 31, 20205,300–Form 10-K (filed 2021-02-25) ↗

Breakdown

What makes up global Full-Time Employees

Cite this data

StockData. (2026). BeOne Medicines Global Full-Time Employees, annual FY2020–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/emp-total

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.